Tag: Valiant Navion
Medtronic provides updated patient management recommendations regarding Valiant Navion recall
This week Medtronic announced that it has sent physicians updated patient management recommendations related to its voluntary recall of the Valiant Navion thoracic stent...
Medtronic announces voluntary recall of unused Valiant Navion thoracic stent graft...
Medtronic has voluntarily issued a global recall of its Valiant Navion thoracic stent graft system and informed physicians to immediately cease use of the...
Medtronic begins real-world, post-market study of Valiant Navion in patients with...
Medtronic today announced the start of a prospective, observational, global, multicentre, real-world, post-market study to evaluate the safety and effectiveness of the Valiant Navion...
Medtronic presents one-year Valiant Navion, four-year ANCHOR registry clinical outcomes
Medtronic has announced one-year outcomes for the Valiant Navion thoracic stent graft system for thoracic endovascular repair (TEVAR) and four-year clinical outcomes from the ANCHOR...
Medtronic announces Shonin approval and launch of the Valiant Navion thoracic...
Medtronic today announced Shonin approval from the Ministry of Health, Labour and Welfare (MHLW) and the launch of the Valiant Navion thoracic stent graft...
BIBA Briefings: Medtronic receives US FDA Breakthrough Device Designation for complex...
The US Food and Drug Administration (FDA) has granted Breakthrough Device Designation to Medtronic for its novel Valiant thoracoabdominal aneurysm (TAAA) stent graft. A...
Medtronic receives FDA breakthrough device designation for its Valiant Navion LSA...
Medtronic today announced it has received breakthrough device designation from the US Food and Drug Administration (FDA) for its Valiant TAAA stent graft system...
Design of Valiant Navion “improves upon current-generation TEVAR”
In the Aortic Podium 1st session at the 2019 Charing Cross Symposium (CX; 15–18 April, London, UK), Fabio Verzini (Turin, Italy) reported the 30-day...
FDA approves Valiant NAVION for inclusion in physician-sponsored IDE
The Valiant NAVION stent graft system (Medtronic) has been approved by the US Food and Drug Administration (FDA) for inclusion in a physician-sponsored investigational...
Valiant Navion receives CE mark approval
CE mark approval has been granted for the Valiant Navion thoracic stent graft system (Medtronic) for the minimally invasive repair of all lesions of...
Valiant Navion thoracic stent graft receives FDA approval
The US Food and Drug Administration (FDA) has approved Valiant Navion thoracic stent graft system (Medtronic) for the minimally invasive repair of all lesions...
